distinguish between drugs according to their potential effect on patients. A more plausible explanation is that drugs receiving priority review tend to have shorter development times and the FDA approves them more quickly; thus, their patents are effective for more years after their approval.
No takes yet. Share an insight, caveat, or question.
Goffredo et al. (2015) studied this question.